Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/6095
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Laktabai, Jeremiah | - |
dc.date.accessioned | 2022-03-17T07:16:33Z | - |
dc.date.available | 2022-03-17T07:16:33Z | - |
dc.date.issued | 2018 | - |
dc.identifier.uri | http://ir.mu.ac.ke:8080/jspui/handle/123456789/6095 | - |
dc.description.abstract | The objective of this experiment is to identify the combination of RDT and conditional (diagnosisdependent) ACT subsidies that maximize the percent of clients receiving an RDT. We will test two different RDT price levels and two discounted ACT price levels in a factorial design. ACT discounts are conditional on a positive RDT result. The primary outcome measure is the decision to purchase an RDT before purchasing a drug. Secondary outcome measures are: Decision to purchase an ACT stratified by testing status: (a.) Positive mRDT (b.) Negative mRDT (c.) No malaria test. All outcomes will be measured by interviewing the participant after they make their decision about whether to be tested and which medicines to purchase. | en_US |
dc.description.sponsorship | NIH-NIAID | en_US |
dc.language.iso | en | en_US |
dc.publisher | Moi University | en_US |
dc.subject | Malaria | en_US |
dc.subject | Diagnostic | en_US |
dc.subject | Testing | en_US |
dc.title | A randomized experiment of malaria diagnostic testing and conditional subsidies to target ACTs in the retail sector: the TESTsmART trial AIM 1 | en_US |
dc.type | Article | en_US |
Appears in Collections: | School of Medicine |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.